International Normalized Ratio

What your INR (international normalized ratio) means depends first on one question: do you take warfarin? If you don't, an INR around 1 (0.8 to 1.2) is normal, and a high result is a finding your clinician should explain. If you do take warfarin, a blood thinner sold as Coumadin or Jantoven, a high INR is the point of the drug, and the number that matters is whether it sits inside the target band your prescriber set, most often 2.0 to 3.0 ¹.

What the INR measures

The INR starts from the prothrombin time (PT), the number of seconds it takes a sample of your plasma (the liquid part of blood) to clot in a tube after the lab adds a test chemical called thromboplastin. Three of the clotting factors the PT depends on (factors II, VII and X) need vitamin K to work. Warfarin blocks vitamin K recycling, which is why it is called a vitamin K antagonist and why it stretches the PT ¹.

Raw PT seconds differ from lab to lab because each lab's thromboplastin differs slightly in strength. The World Health Organization adopted the INR system in 1983 to fix that, based on a calibration method published that year ⁷. The formula divides your PT by the lab's normal PT and applies a correction number for each chemical batch, called the ISI (International Sensitivity Index). The result is that an INR of 2.5 means the same thing in Boston and in Phoenix.

An INR therefore describes clotting capacity in a test tube. An INR cannot show whether you have a blood clot right now; the test used to help rule a clot in or out is the D-dimer. The INR's sister tests are the aPTT and fibrinogen, the clotting protein the final step of clotting depends on.

Normal INR and warfarin target ranges

For most people taking warfarin for a blood clot in the leg or lung (venous thromboembolism) or for atrial fibrillation (an irregular heart rhythm that raises stroke risk; see the heart hub), the CHEST guideline from the American College of Chest Physicians sets a band of 2.0 to 3.0 ¹.

We recommend a therapeutic INR range of 2.0 to 3.0 (target INR of 2.5) rather than a lower (INR < 2) or higher (INR 3.0-5.0) range.Holbrook et al., CHEST 2012 (ACCP 9th ed.), grade 1B, a strong recommendation from moderate-quality evidence ¹

Mechanical heart valves are the main exception. The 2020 American College of Cardiology and American Heart Association valve guideline sets a target of 3.0 (range 2.5 to 3.5) for a mechanical mitral valve, or for a mechanical aortic valve plus extra clot risk factors, and 2.5 for a bileaflet mechanical aortic valve without those risk factors ². Your own band is the one written on your anticoagulation plan.

What pushes the INR up or down

Warfarin has a narrow window between too little and too much, so small changes show up in the INR within days. The common causes below come from the warfarin prescribing information and CHEST guidance ^{1 8}.

On warfarin, keep vitamin K intake steady rather than low. Big swings in leafy greens move the INR, and a consistent diet keeps it predictable ¹.

Supplements belong on the list you give your clinic too. St John's wort and some other herbal products are listed as possible warfarin interactions in the Coumadin prescribing information ⁸. Tell the clinic about every supplement, including fish oil (omega-3) and vitamin C, before you start or stop one. No supplement is a way to adjust your INR.

How the INR test is done and how often

• No fasting is needed. Most clinics don't ask you to change when you take warfarin before the test; follow your clinic's instructions.
• The lab draws blood into a light-blue-top tube containing citrate, a chemical that stops the sample clotting before testing; a clinic or home meter uses a fingerstick drop instead.
• It is usually ordered as "PT/INR", often alone, sometimes alongside the aPTT in a pre-surgery coagulation panel.
• It is one of the cheaper routine lab tests and is generally covered by insurance when there is a medical reason, such as warfarin monitoring or planned surgery.

On warfarin, testing is frequent at the start, often every few days, until doses settle. Once the INR has been steady, the CHEST 2012 guideline suggests testing can stretch to as long as every 12 weeks rather than every 4 weeks for people whose readings stay stable ¹. Any new medicine, illness, hospital stay or big diet change is a reason your clinic may check sooner.

Clinics judge control by time in therapeutic range (TTR), the share of days your INR is estimated to sit inside your band. UK NICE guidance uses a TTR below 65% as a marker of poor control ⁹. A single reading matters less than the run of readings, the point made in why trends beat single readings.

Home INR meters suit some long-term warfarin users, usually after training and with a clinic receiving the results. In the Heneghan 2012 meta-analysis, people who self-monitored at home had fewer clots without a significant change in major bleeding ⁴. In these trials, self-management meant trained, selected patients following a written dosing plan agreed with their clinic. It is not a reason to change your dose without that plan; ask your clinic whether home testing suits you. In the US, Medicare has covered home INR monitoring for some groups, including people with mechanical valves, atrial fibrillation or venous thromboembolism ¹⁰; check current coverage with your plan.

Why the INR doesn't track the newer blood thinners

DOACs (direct oral anticoagulants) block one clotting factor directly instead of working through vitamin K. They include apixaban (Eliquis), rivaroxaban (Xarelto), edoxaban (Savaysa) and dabigatran (Pradaxa). They are prescribed at fixed doses and do not need routine blood monitoring. The INR responds to them unpredictably: apixaban can leave the PT and INR normal at therapeutic levels ⁵.

If you take a DOAC and an INR appears on your results, it was probably part of a routine or pre-surgery panel. It tells you about your clotting factors; it cannot tell you whether your blood thinner is working. That needs a drug-specific test, which is rarely ordered outside emergencies.

A raised INR when you are not on warfarin

Off warfarin, an INR above about 1.2 has a short list of usual explanations: low vitamin K (poor diet, long antibiotic courses, conditions that block fat absorption), liver disease, other blood thinners (rivaroxaban and some other DOACs, or heparin, can raise it), lab handling problems such as an underfilled tube, and rarer inherited factor deficiencies. Less often it signals something urgent: accidental swallowing of an anticoagulant such as rat poison, or DIC (disseminated intravascular coagulation, widespread clotting that uses up clotting factors in a very sick person). The liver makes most clotting factors, which is why a raised INR often sits next to abnormal results described in liver enzymes explained.

In cirrhosis (advanced liver scarring), the liver also makes less of the body's natural anticoagulants, protein C and antithrombin, so a high INR in liver disease does not reliably predict bleeding ⁶. The INR is still one of the inputs to the MELD score (Model for End-stage Liver Disease), which ranks how ill the liver is for transplant listing. Earlier-stage conditions such as fatty liver usually leave the INR normal.

For how labs build normal ranges in the first place, see reference ranges explained. New to lab reports? Start with how to read any lab result. The full set of clotting tests sits on the blood clotting hub, liver-related markers on the liver hub, and the heart conditions that most often lead to warfarin on the heart hub.

LifeFrom explains lab results for general education. It is not a medical provider and cannot diagnose you or manage your anticoagulation. Decisions about warfarin, DOACs, supplements or further testing belong with your prescriber or anticoagulation clinic.

Your results, in contextAdd the lab results you already have, and LifeFrom reads each marker next to the others it moves with, in plain language, with the sources it used.Get started